IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Onkure Therapeutics Inc (OKUR)

CUSIP: 68277Q105 | NYSE | Healthcare · Biotechnology | Micro Cap | 115 institutional holders

Quarters

Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Beneficial Ownership — 13D / 13G

Full history →

5%+ stakes reported outside the quarterly cycle. A 13D is due within five business days of the event below, so these figures lead the holders table until the filer's next 13F catches up to them.

HolderShares% of ClassChangeEvent Datevs 13F
13GCoastlands Capital Partners LP2,700,0006.7%New 5%+ stakeOct 1, 2026No 13F filer matched
13G/ABVF Partners L P
with BVF GP Holdings LLC, Biotechnology Value Fund L P, BVF I GP LLC, +4 more

Institutional Holders — Q3 2026

Dimensional Fund Advisors LP76,928
0.0% of portfolio›$209.2K
Bank of New York Mellon Corp72,215
0.0% of portfolio›$196.8K
Citigroup Inc14,297
0.0% of portfolio›$39.0K
Sterling Capital Management LLC495
0.0% of portfolio›$1.3K
SJS Investment Consulting Inc.51
0.0% of portfolio›$139
IFP Advisors, Inc18
0.0% of portfolio›$49
StyleTurnoverLocationFiled
Dimensional Fund Advisors LP
76,928$209.2K0.0%IndexLowAustin, TX2026-11-04
Bank of New York Mellon Corp
72,215$196.8K0.0%CoreLowNew York, NY2026-11-05
Citigroup Inc
14,297$39.0K0.0%CoreMediumNew York, NY2026-11-04
Sterling Capital Management LLC
495$1.3K0.0%GARPMediumCharlotte, NC2026-10-22
SJS Investment Consulting Inc.
51$1390.0%ETFVery LowSylvania, OH2026-10-26
IFP Advisors, Inc
18$490.0%GrowthLowTampa, FL2026-10-16
3,235,778
8.0%
New 5%+ stake
Jun 30, 2026
No 13F filer matched
13G/AAdar1 Capital Management, LLC
with Adar1 Capital Management GP, LLC
2,238,6845.5%New 5%+ stakeJun 30, 2026No 13F filer matched
13DAI Biotechnology LLC9,091,53220.0%New 5%+ stakeMar 31, 2026No 13F filer matched
13GCoastlands Capital Partners LP2,700,000
6.7% of class · Oct 1, 2026New 5%+ stake
No 13F filer matched
13G/ABVF Partners L P3,235,778
8.0% of class · Jun 30, 2026New 5%+ stake
with BVF GP Holdings LLC, Biotechnology Value Fund L P, BVF I GP LLC, +4 more
No 13F filer matched
13G/AAdar1 Capital Management, LLC2,238,684
5.5% of class · Jun 30, 2026New 5%+ stake
with Adar1 Capital Management GP, LLC
No 13F filer matched
13DAI Biotechnology LLC9,091,532
20.0% of class · Mar 31, 2026New 5%+ stake
No 13F filer matched